• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实体瘤中的缺氧:癌症干细胞(CSC)耐药性的关键促进因素。

Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.

机构信息

Radiology and Nuclear Medicine Department, School of Paramedical Sciences, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Departments of Medical Physics and Radiology, Faculty of Paramedical Sciences, Kashan University of Medical Sciences, Kashan, Iran.

出版信息

J Cancer Res Clin Oncol. 2020 Jan;146(1):19-31. doi: 10.1007/s00432-019-03080-1. Epub 2019 Nov 16.

DOI:10.1007/s00432-019-03080-1
PMID:31734836
Abstract

PURPOSE

Cancer stem cells (CSCs) are highly tumorigenic cell types that reside within specific areas of tumor microenvironment (TME), and are endowed with self-renewal and resistance properties. Here, we aimed to discuss mechanisms involved in hypoxia-derived CSC resistance and targeting for effective cancer therapy.

RESULTS

Preferential localization within hypoxic niches would help CSCs develop adaptive mechanisms, mediated through the modification of responses to various stressors and, as a result, show a more aggressive behavior.

CONCLUSION

Hypoxia, in fact, serves as a multi-tasking strategy to nurture CSCs with this adaptive capacity, complexing targeted therapies.

摘要

目的

癌症干细胞(CSCs)是高度致瘤性的细胞类型,存在于肿瘤微环境(TME)的特定区域,并具有自我更新和抵抗特性。在这里,我们旨在讨论缺氧衍生的 CSC 抵抗机制及其作为有效癌症治疗的靶点。

结果

在缺氧生态位中的优先定位将有助于 CSCs 发展适应机制,通过对各种应激源的反应的修饰来介导,并且结果表现出更具侵略性的行为。

结论

事实上,缺氧作为一种多任务策略,为具有这种适应能力的 CSCs 提供营养,使靶向治疗复杂化。

相似文献

1
Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.实体瘤中的缺氧:癌症干细胞(CSC)耐药性的关键促进因素。
J Cancer Res Clin Oncol. 2020 Jan;146(1):19-31. doi: 10.1007/s00432-019-03080-1. Epub 2019 Nov 16.
2
Preventive cancer stem cell-based vaccination modulates tumor development in syngeneic colon adenocarcinoma murine model.基于预防癌症干细胞的疫苗接种可调节同种异体结肠腺癌小鼠模型中的肿瘤发展。
J Cancer Res Clin Oncol. 2023 Jul;149(7):4101-4116. doi: 10.1007/s00432-022-04303-8. Epub 2022 Aug 30.
3
Heterogeneous protein dynamics links to mitochondrial activity, glucose transporter, and ALDH cancer stem cell properties.异质性蛋白质动力学与线粒体活性、葡萄糖转运蛋白及醛脱氢酶癌症干细胞特性相关。
BMC Cancer. 2025 Jul 1;25(1):1085. doi: 10.1186/s12885-025-14460-x.
4
Tb-Based Anti-L1CAM Radioimmunotherapy Shows Superior Efficacy in Eliminating Ovarian Cancer Stem Cells Compared with Lu in Preclinical Models of Ovarian Cancer.在卵巢癌临床前模型中,基于铽的抗L1细胞粘附分子放射免疫疗法在消除卵巢癌干细胞方面比镥显示出更高的疗效。
J Nucl Med. 2025 Jul 1;66(7):1091-1096. doi: 10.2967/jnumed.124.269078.
5
Adipocytes promote cancer stemness properties in oral squamous cell carcinoma through C3/C3AR axis and sphingolipid metabolism.脂肪细胞通过C3/C3AR轴和鞘脂代谢促进口腔鳞状细胞癌的癌症干性特性。
Cancer Lett. 2025 Sep 28;628:217848. doi: 10.1016/j.canlet.2025.217848. Epub 2025 Jun 6.
6
Deciphering normal and cancer stem cell niches by spatial transcriptomics: opportunities and challenges.通过空间转录组学解析正常和癌症干细胞微环境:机遇与挑战
Genes Dev. 2025 Jan 7;39(1-2):64-85. doi: 10.1101/gad.351956.124.
7
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.草药类营养保健品:抗击肿瘤缺氧的安全有效治疗手段。
J Cancer Res Clin Oncol. 2020 Jan;146(1):1-18. doi: 10.1007/s00432-019-03068-x. Epub 2019 Nov 13.
8
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer.三阴性乳腺癌中与化疗耐药相关的癌症干细胞存活途径的最新进展。
Future Oncol. 2025 Mar;21(6):715-735. doi: 10.1080/14796694.2025.2461443. Epub 2025 Feb 12.
9
Cancer stem cells amino acid metabolism: Roles, mechanisms, and intervention strategies.癌症干细胞的氨基酸代谢:作用、机制及干预策略。
Cell Signal. 2025 Oct;134:111903. doi: 10.1016/j.cellsig.2025.111903. Epub 2025 May 29.
10
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.靶向癌症干细胞以克服耐药性和肿瘤复发的纳米材料。
Front Oncol. 2025 Jun 6;15:1499283. doi: 10.3389/fonc.2025.1499283. eCollection 2025.

引用本文的文献

1
Selection of Stable Reference Genes for Gene Expression Studies in Activated and Non-Activated PBMCs Under Normoxic and Hypoxic Conditions.在常氧和低氧条件下活化及未活化外周血单个核细胞中用于基因表达研究的稳定内参基因的选择
Int J Mol Sci. 2025 Jul 15;26(14):6790. doi: 10.3390/ijms26146790.
2
β-Catenin Drives the FOXC2-Mediated Epithelial-Mesenchymal Transition and Acquisition of Stem Cell Properties.β-连环蛋白驱动FOXC2介导的上皮-间质转化及干细胞特性的获得。
Cancers (Basel). 2025 Mar 26;17(7):1114. doi: 10.3390/cancers17071114.
3
Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases.

本文引用的文献

1
Cancer stem cell (CSC) resistance drivers.癌症干细胞(CSC)耐药性驱动因素。
Life Sci. 2019 Oct 1;234:116781. doi: 10.1016/j.lfs.2019.116781. Epub 2019 Aug 17.
2
Regulates the Stemness Pathway via and to Maintain Self-Renewal in Cancer Stem Cells versus Non-Stem Cancer Cells.通过 和 调节 干性通路,维持癌症干细胞自我更新与非干性癌症细胞。
Cancer Res. 2019 Aug 15;79(16):4015-4025. doi: 10.1158/0008-5472.CAN-18-2847. Epub 2019 Jul 2.
3
Monitoring tumour microenvironment changes during anti-angiogenesis therapy using functional MRI.
氧化应激与氧化还原失衡:癌症干细胞和神经退行性疾病中的共同机制
Cells. 2025 Mar 29;14(7):511. doi: 10.3390/cells14070511.
4
Battlegrounds of treatment resistance: decoding the tumor microenvironment.治疗耐药的战场:解读肿瘤微环境
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 25. doi: 10.1007/s00210-025-04055-5.
5
The Role of RAC2 and PTTG1 in Cancer Biology.RAC2和PTTG1在癌症生物学中的作用。
Cells. 2025 Feb 23;14(5):330. doi: 10.3390/cells14050330.
6
Ultra‑high dose rate (FLASH) treatment: A novel radiotherapy modality (Review).超高剂量率(FLASH)治疗:一种新型放射治疗模式(综述)。
Mol Clin Oncol. 2025 Jan 9;22(3):23. doi: 10.3892/mco.2025.2818. eCollection 2025 Mar.
7
Insights from a multiscale framework on metabolic rate variation driving glioblastoma multiforme growth and invasion.多尺度框架对驱动多形性胶质母细胞瘤生长和侵袭的代谢率变化的见解。
Commun Eng. 2024 Nov 25;3(1):176. doi: 10.1038/s44172-024-00319-9.
8
Self-assembled aldehyde dehydrogenase-activatable nano-prodrug for cancer stem cell-enriched tumor detection and treatment.用于癌症干细胞富集肿瘤检测和治疗的自组装醛脱氢酶激活型纳米前药。
Nat Commun. 2024 Oct 31;15(1):9417. doi: 10.1038/s41467-024-53771-8.
9
Integrated analysis to identify biological features and molecular markers of poorly cohesive gastric carcinoma (PCC).整合分析鉴定低黏附性胃癌(PCC)的生物学特征和分子标志物。
Sci Rep. 2024 Sep 30;14(1):22596. doi: 10.1038/s41598-024-73062-y.
10
Hypoxia-induced TGFBI maintains glioma stem cells by stabilizing EphA2.缺氧诱导的 TGFBI 通过稳定 EphA2 维持神经胶质瘤干细胞。
Theranostics. 2024 Sep 9;14(15):5778-5792. doi: 10.7150/thno.95141. eCollection 2024.
利用功能磁共振成像监测抗血管生成治疗中的肿瘤微环境变化。
Angiogenesis. 2019 Aug;22(3):457-470. doi: 10.1007/s10456-019-09670-4. Epub 2019 May 30.
4
Distinct Tumor Microenvironment at Tumor Edge as a Result of Astrocyte Activation Is Associated With Therapeutic Resistance for Brain Tumor.星形胶质细胞激活导致肿瘤边缘独特的肿瘤微环境与脑肿瘤的治疗耐药性相关。
Front Oncol. 2019 Apr 26;9:307. doi: 10.3389/fonc.2019.00307. eCollection 2019.
5
Hypoxia-induced secretion stimulates breast cancer stem cell regulatory signalling pathways.缺氧诱导分泌刺激乳腺癌干细胞调控信号通路。
Mol Oncol. 2019 Aug;13(8):1693-1705. doi: 10.1002/1878-0261.12500. Epub 2019 Jun 26.
6
Value of blood oxygenation level-dependent MRI for predicting clinical outcomes in uterine cervical cancer treated with concurrent chemoradiotherapy.血氧水平依赖 MRI 对同期放化疗治疗宫颈癌患者临床结局的预测价值。
Eur Radiol. 2019 Nov;29(11):6256-6265. doi: 10.1007/s00330-019-06198-5. Epub 2019 Apr 23.
7
Rationale for Combining Radiotherapy and Immune Checkpoint Inhibition for Patients With Hypoxic Tumors.联合放疗和免疫检查点抑制剂治疗乏氧肿瘤患者的理由。
Front Immunol. 2019 Mar 12;10:407. doi: 10.3389/fimmu.2019.00407. eCollection 2019.
8
Epithelial-mesenchymal transition induced cancer-stem-cell-like characteristics in hepatocellular carcinoma.上皮-间充质转化诱导肝癌干细胞样特征。
J Cell Physiol. 2019 Aug;234(10):18448-18458. doi: 10.1002/jcp.28480. Epub 2019 Mar 25.
9
Aspirin inhibits hypoxia-mediated lung cancer cell stemness and exosome function.阿司匹林抑制低氧介导的肺癌干细胞特性和外泌体功能。
Pathol Res Pract. 2019 Jun;215(6):152379. doi: 10.1016/j.prp.2019.03.008. Epub 2019 Mar 11.
10
Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features.K63 多聚泛素化 DDX17 调控 miRNA 生成和组蛋白修饰以控制癌症干细胞样特征。
Cancer Res. 2019 May 15;79(10):2549-2563. doi: 10.1158/0008-5472.CAN-18-2376. Epub 2019 Mar 15.